Brookfield Corporation
NYSE:BNAsset Management
-$0.32 today
- Market cap
- $87.93B
- Beta
- 1.84
- P/E (TTM)
- 83.3
- EPS (TTM)
- $0.53
- Dividend yield
- 0.59%
Volume 2.78M
Average 5.35M
BN EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
Brookfield CorporationNYSE: BN
EBITDA · Q3 FY2026 · quarter ended Sep 2026
EBITDA grows in line with its trailing trend
Q3 FY2026 EBITDA of $9.45B rose 15.1% year over year, ahead of the +13.3% change in trailing-twelve-month EBITDA. Sequentially, it rose 16.9% from the prior quarter. Over 3 fiscal years it compounded at +8.3% a year.
Context
- EBITDA amounted to 42.4% of revenue in FY2025, up 8.5 pp from a year earlier.
- EBITDA increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether EBITDA reaches the consensus estimate from 1 analysts of $16.63B (-47.8%) for the fiscal year ending Dec 2026, a slowdown from the +9.1% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterSep 2026
- $9.45B+16.9% QoQ
- Last fiscal yearDec 2025
- $31.85B+9.1% YoY
- LTMSep 2026
- $34.73B+13.3% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +15.1% | -53.5% | -68.6 pp |
| 1 year | +9.1% | -47.8% | -56.9 pp |
| 3-year CAGR | +8.3% | -19.0% | -27.4 pp |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2025
- 31.85B USD
- Year-over-year change
- +9.1%
- 4-year CAGR
- +2.6%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 31.85B | +9.1% |
| FY2024 | 2024-12-31 | 29.19B | -4.9% |
| FY2023 | 2023-12-31 | 30.69B | +22.5% |
| FY2022 | 2022-12-31 | 25.05B | -12.9% |
| FY2021 | 2021-12-31 | 28.75B | — |
EBITDA vs competitors
How BN compares with its peers on the latest reported figures
- BN's LTM Sep 2026 EBITDA of $34.73B is the highest of the 8 companies compared; the peer median is $2.48B.
- Its year-over-year change of +13.3% is the 5th highest of 7, against a peer median of +18.4%.
- EBITDA amounts to 43.9% of revenue for BN, versus a peer median of 31.8%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $34.73B | +13.3% | +8.3% | 43.9% | |
| LTM Sep 2026 | $10.23B | +10.2% | +96.2% | 50.8% | |
| LTM Jun 2026 | $9.45B | +28.0% | — | 26.3% | |
| LTM Sep 2026 | $8.63B | +34.5% | +26.9% | 52.9% | |
| LTM Jun 2026 | $2.48B | +18.4% | +19.8% | 38.9% | |
| LTM Jun 2026 | $951.82M | +18.4% | +51.4% | 31.8% | |
| LTM Sep 2026 | $836.7M | -27.4% | -5.0% | 23.8% | |
| LTM Jun 2026 | -$74.56M | — | — | 9.7% | |
| Peer median (excluding BN) | $2.48B | +18.4% | +26.9% | 31.8% | |
Competitors are the stored peer set for BN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 75.73B | 92.77B | 95.92B | 86.01B | 75.1B |
| Cost of Revenue | 64B | 78.51B | 81.41B | 67.94B | 56.97B |
| Gross Profit | 11.73B | 14.26B | 14.52B | 18.07B | 18.13B |
| Gross Margin | 15.5% | 15.4% | 15.1% | 21.0% | 24.1% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 116M | 122M | 69M | 76M | 78M |
| Operating Expenses | 116M | 122M | 69M | 76M | 78M |
| Depreciation & Amortization | 6.44B | 7.68B | 9.08B | 9.74B | 10.38B |
| EBITDA | 28.75B | 25.05B | 30.69B | 29.19B | 31.85B |
| EBITDA Margin | 38.0% | 27.0% | 32.0% | 33.9% | 42.4% |
| Operating Income | 11.62B | 14.14B | 14.45B | 17.99B | 18.05B |
| Operating Margin | 15.3% | 15.2% | 15.1% | 20.9% | 24.0% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 7.6B | 10.7B | 15.5B | 16.62B | 17.1B |
| Other Income / Expenses | 3.1B | (7.47B) | (8.33B) | (15.16B) | (13.68B) |
| Income Before Tax | 14.71B | 6.66B | 6.12B | 2.84B | 4.37B |
| Pre-Tax Margin | 19.4% | 7.2% | 6.4% | 3.3% | 5.8% |
| Income Tax Expense | 2.32B | 1.47B | 1.01B | 982M | 1.14B |
| Net Income | 3.97B | 2.06B | 1.13B | 641M | 1.31B |
| Net Margin | 5.2% | 2.2% | 1.2% | 0.7% | 1.7% |
| EPS (Basic) | 1.65 | 0.81 | 0.41 | 0.21 | 0.51 |
| EPS (Diluted) | 1.59 | 0.79 | 0.41 | 0.21 | 0.49 |
| Weighted Avg Shares | 2.3B | 2.35B | 2.34B | 2.27B | 2.25B |
| Weighted Avg Shares (Diluted) | 2.38B | 2.41B | 2.38B | 2.38B | 2.37B |
Brookfield Corporation
NYSE:BN
Intrinsic Alpha fair value
Locked
Current Price
$39.39
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.